Literature DB >> 19519745

Blocking UV-induced eIF2alpha phosphorylation with small molecule inhibitors of GCN2.

Francis Robert1, Chris Williams, Yifei Yan, Elizabeth Donohue, Regina Cencic, Stephen K Burley, Jerry Pelletier.   

Abstract

The eIF2alpha kinase general control non-depressible 2 integrates translation initiation rates to amino acid availability. General control non-depressible 2 also regulates translation initiation during synaptic plasticity and GCN2(-/-) mice show improved memory compared with wild-type mice with a reduced threshold for triggering late long-term potentiation. This property suggests that inhibiting general control non-depressible 2 function might represent a therapeutic avenue for improving memory. We screened for general control non-depressible 2 inhibitors using a small library of known kinase inhibitors and ATP-analogs and identified three compounds--indirubin-3'-monoxime, SP600125 and a SyK inhibitor with activity against general control non-depressible 2. All three compounds inhibit the ability of general control non-depressible 2 to phosphorylate eIF2alphain vitro as well as in vivo following UV-treatment of mouse embryonic fibroblasts. Using computer-assisted modeling, we modeled the binding of the inhibitors in the ATP-binding site of general control non-depressible 2. This work provides the molecular basis for undertaking structure-activity relationships of these compounds in order to develop specific inhibitors of general control non-depressible 2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519745      PMCID: PMC8221234          DOI: 10.1111/j.1747-0285.2009.00827.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  36 in total

1.  Mutations that bypass tRNA binding activate the intrinsically defective kinase domain in GCN2.

Authors:  Hongfang Qiu; Cuihua Hu; Jinsheng Dong; Alan G Hinnebusch
Journal:  Genes Dev       Date:  2002-05-15       Impact factor: 11.361

2.  Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors.

Authors:  J A Bertrand; S Thieffine; A Vulpetti; C Cristiani; B Valsasina; S Knapp; H M Kalisz; M Flocco
Journal:  J Mol Biol       Date:  2003-10-17       Impact factor: 5.469

3.  Structural basis for autoinhibition and mutational activation of eukaryotic initiation factor 2alpha protein kinase GCN2.

Authors:  Anil K Padyana; Hongfang Qiu; Antonina Roll-Mecak; Alan G Hinnebusch; Stephen K Burley
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

4.  Tight binding of the phosphorylated alpha subunit of initiation factor 2 (eIF2alpha) to the regulatory subunits of guanine nucleotide exchange factor eIF2B is required for inhibition of translation initiation.

Authors:  T Krishnamoorthy; G D Pavitt; F Zhang; T E Dever; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory.

Authors:  Mauro Costa-Mattioli; Delphine Gobert; Elad Stern; Karine Gamache; Rodney Colina; Claudio Cuello; Wayne Sossin; Randal Kaufman; Jerry Pelletier; Kobi Rosenblum; Kresimir Krnjević; Jean-Claude Lacaille; Karim Nader; Nahum Sonenberg
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

6.  Regulated translation initiation controls stress-induced gene expression in mammalian cells.

Authors:  H P Harding; I Novoa; Y Zhang; H Zeng; R Wek; M Schapira; D Ron
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

7.  Glucose limitation induces GCN4 translation by activation of Gcn2 protein kinase.

Authors:  R Yang; S A Wek; R C Wek
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

8.  Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?

Authors:  S Leclerc; M Garnier; R Hoessel; D Marko; J A Bibb; G L Snyder; P Greengard; J Biernat; Y Z Wu; E M Mandelkow; G Eisenbrand; L Meijer
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

9.  The specificities of protein kinase inhibitors: an update.

Authors:  Jenny Bain; Hilary McLauchlan; Matthew Elliott; Philip Cohen
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

10.  Activation of GCN2 in UV-irradiated cells inhibits translation.

Authors:  Jing Deng; Heather P Harding; Brian Raught; Anne-Claude Gingras; Juan Jose Berlanga; Donalyn Scheuner; Randal J Kaufman; David Ron; Nahum Sonenberg
Journal:  Curr Biol       Date:  2002-08-06       Impact factor: 10.834

View more
  16 in total

1.  Cellular adaptation to nutrient deprivation: crosstalk between the mTORC1 and eIF2α signaling pathways and implications for autophagy.

Authors:  Jordan C Wengrod; Lawrence B Gardner
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Role of eIF2α Kinases in Translational Control and Adaptation to Cellular Stress.

Authors:  Ronald C Wek
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

Review 3.  Therapeutic Opportunities in Eukaryotic Translation.

Authors:  Jennifer Chu; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

4.  The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.

Authors:  Piyawan Bunpo; Judy K Cundiff; Rachel B Reinert; Ronald C Wek; Carla J Aldrich; Tracy G Anthony
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

Review 5.  The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration.

Authors:  Sarah Bond; Claudia Lopez-Lloreda; Patrick J Gannon; Cagla Akay-Espinoza; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2020-02-01       Impact factor: 3.685

6.  Stimulators of translation identified during a small molecule screening campaign.

Authors:  Unkyung Shin; David E Williams; Dima Kozakov; David R Hall; Dmitri Beglov; Sandor Vajda; Raymond J Andersen; Jerry Pelletier
Journal:  Anal Biochem       Date:  2014-02-15       Impact factor: 3.365

Review 7.  The integrated stress response: From mechanism to disease.

Authors:  Mauro Costa-Mattioli; Peter Walter
Journal:  Science       Date:  2020-04-24       Impact factor: 47.728

Review 8.  Biology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy.

Authors:  Scott M Ebert; Blake B Rasmussen; Andrew R Judge; Sarah M Judge; Lars Larsson; Ronald C Wek; Tracy G Anthony; George R Marcotte; Matthew J Miller; Mark A Yorek; Adrian Vella; Elena Volpi; Jennifer I Stern; Matthew D Strub; Zachary Ryan; John J Talley; Christopher M Adams
Journal:  J Nutr       Date:  2022-04-01       Impact factor: 4.798

Review 9.  The integrated stress response.

Authors:  Karolina Pakos-Zebrucka; Izabela Koryga; Katarzyna Mnich; Mila Ljujic; Afshin Samali; Adrienne M Gorman
Journal:  EMBO Rep       Date:  2016-09-14       Impact factor: 8.807

Review 10.  Targeting the integrated stress response in ophthalmology.

Authors:  Hsiao-Sang Chu; Cornelia Peterson; Albert Jun; James Foster
Journal:  Curr Eye Res       Date:  2021-01-21       Impact factor: 2.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.